Hamilton County, Ohio, plans to distribute 30,000 units of the opioid overdose reversal drug—a more than fourfold increase, in today's bite-sized hospital and health industry news from California/Texas, Ohio, and Tennessee.
The Senate Health, Education, Labor and Pensions (HELP) Committee this week heard from a bipartisan group of state insurance officials and governors as part of its series of hearings on a short-term bill to improve the individual health insurance market. The hearings will continue next week, but it's not clear whether lawmakers have enough time and support to pass a short-term bill before Sept. 30.
As Florida prepares for Hurricane Irma—a Category 5 storm, expected to make landfall this weekend—hospitals are beginning to evacuate patients, and hospital executives who've been through previous storms are offering their advice.
Doug Smith, associate medical director at Intermountain Healthcare, said, "Patients with acute or chronic pain conditions will still be able to get the medications they need. ... We will ensure patients have access to the full range of options to manage pain."
A study published in the Annals of Internal Medicine states that the controversial prostate-specific antigen (PSA) screening for prostate cancer "can significantly reduce the risk for prostate cancer death," but critics say the screening could lead to over-diagnosing and unnecessary treatments.
A critical care physician reflects on what he learned from a decision to proceed with treatment for a family member with a life-threatening illness against the patient's previously expressed wishes.
Spurred by controversies such as the EpiPen price debate and the shift toward alternative payment models, the health care industry is experimenting with new ways to improve pricing transparency, Maria Castellucci and Shelby Livingston write for Modern Healthcare.
